# A Crossover Study in the Treatment of Patients With COPD

> **NCT00462540** · PHASE3 · COMPLETED · sponsor: **Dey** · enrollment: 100 (estimated)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** Formoterol Fumurate inhalation solution 20 mcg
- **DRUG:** Ipratropium bromide 18 mcg and albuterol sulfate 103 mcg

## Key facts

- **NCT ID:** NCT00462540
- **Lead sponsor:** Dey
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2007-09
- **Final completion:** 2007-10
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2009-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00462540

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00462540, "A Crossover Study in the Treatment of Patients With COPD". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00462540. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*